{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:13:17Z","timestamp":1648739597027},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s11033-014-3662-z","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T12:19:47Z","timestamp":1407154787000},"page":"7697-7704","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dilazep synergistically reactivates latent HIV-1 in latently infected cells"],"prefix":"10.1007","volume":"41","author":[{"given":"Hanxian","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhishuo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanzhang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"3662_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","volume":"387","author":"T-W Chun","year":"1997","unstructured":"Chun T-W, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183\u2013188","journal-title":"Nature"},{"issue":"2","key":"3662_CR2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.virol.2010.12.041","volume":"411","author":"MJ Pace","year":"2011","unstructured":"Pace MJ, Agosto L, Graf EH, O\u2019Doherty U (2011) HIV reservoirs and latency models. Virology 411(2):344\u2013354","journal-title":"Virology"},{"issue":"5919","key":"3662_CR3","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","volume":"323","author":"DD Richman","year":"2009","unstructured":"Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ (2009) The challenge of finding a cure for HIV infection. Science 323(5919):1304\u20131307","journal-title":"Science"},{"issue":"1","key":"3662_CR4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/COH.0b013e328340ffbb","volume":"6","author":"J Karn","year":"2011","unstructured":"Karn J (2011) The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit. Curr Opin HIV AIDS 6(1):4\u201311","journal-title":"Curr Opin HIV AIDS"},{"issue":"9","key":"3662_CR5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1086\/428777","volume":"191","author":"MC Strain","year":"2005","unstructured":"Strain MC, Little SJ, Daar ES, Havlir DV, G\u00fcnthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA (2005) Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis 191(9):1410\u20131418","journal-title":"J Infect Dis"},{"issue":"6","key":"3662_CR6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9(6):727\u2013728","journal-title":"Nat Med"},{"key":"3662_CR7","unstructured":"UNAIDS (2013) Global Report 2012: UNAIDS Report on the global AIDS epidemic. ebookpartnership. com"},{"issue":"9883","key":"3662_CR8","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0140-6736(13)60104-X","volume":"381","author":"C Katlama","year":"2013","unstructured":"Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, Miller M, Vella S, Schmitz JE, Ahlers J, Richman DD, Sekaly RP (2013) Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet 381(9883):2109\u20132117. doi: 10.1016\/s0140-6736(13)60104-x","journal-title":"Lancet"},{"issue":"1","key":"3662_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/COH.0b013e32834124fd","volume":"6","author":"JK Chan","year":"2011","unstructured":"Chan JK, Greene WC (2011) NF-kappaB\/Rel: agonist and antagonist roles in HIV-1 latency. Curr Opin HIV AIDS 6(1):12\u201318. doi: 10.1097\/COH.0b013e32834124fd","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"3662_CR10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrmicro2223","volume":"7","author":"M Coiras","year":"2009","unstructured":"Coiras M, Lopez-Huertas MR, Perez-Olmeda M, Alcami J (2009) Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol 7(11):798\u2013812. doi: 10.1038\/nrmicro2223","journal-title":"Nat Rev Microbiol"},{"key":"3662_CR11","doi-asserted-by":"crossref","first-page":"574967","DOI":"10.1155\/2012\/574967","volume":"2012","author":"W Abbas","year":"2012","unstructured":"Abbas W, Herbein G (2012) Molecular understanding of HIV-1 latency. Adv Virol 2012:574967. doi: 10.1155\/2012\/574967","journal-title":"Adv Virol"},{"issue":"1","key":"3662_CR12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/clpt.2012.202","volume":"93","author":"KM Barton","year":"2013","unstructured":"Barton KM, Burch BD, Soriano-Sarabia N, Margolis DM (2013) Prospects for treatment of latent HIV. Clin Pharmacol Ther 93(1):46\u201356. doi: 10.1038\/clpt.2012.202","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"3662_CR13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00002030-200405210-00003","volume":"18","author":"L Ylisastigui","year":"2004","unstructured":"Ylisastigui L, Archin NM, Lehrman G, Bosch RJ, Margolis DM (2004) Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18(8):1101\u20131108","journal-title":"AIDS"},{"issue":"11","key":"3662_CR14","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1074\/jbc.M807898200","volume":"284","author":"X Contreras","year":"2009","unstructured":"Contreras X, Schweneker M, Chen C-S, McCune JM, Deeks SG, Martin J, Peterlin BM (2009) Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem 284(11):6782\u20136789","journal-title":"J Biol Chem"},{"issue":"7408","key":"3662_CR15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","volume":"487","author":"NM Archin","year":"2012","unstructured":"Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM, Parker DC, Anderson EM, Kearney MF, Strain MC, Richman DD, Hudgens MG, Bosch RJ, Coffin JM, Eron JJ, Hazuda DJ, Margolis DM (2012) Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487(7408):482\u2013485. doi: 10.1038\/nature11286","journal-title":"Nature"},{"issue":"25","key":"3662_CR16","doi-asserted-by":"crossref","first-page":"22211","DOI":"10.1074\/jbc.M110.180224","volume":"286","author":"K Huber","year":"2011","unstructured":"Huber K, Doyon G, Plaks J, Fyne E, Mellors JW, Sluis-Cremer N (2011) Inhibitors of histone deacetylases correlation between isoform specificity and reactivation of HIV Type 1 (HIV-1) from latently infected cells. J Biol Chem 286(25):22211\u201322218","journal-title":"J Biol Chem"},{"issue":"1","key":"3662_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0b013e3181d3dca3","volume":"54","author":"S Matalon","year":"2010","unstructured":"Matalon S, Palmer BE, Nold MF, Furlan A, Kassu A, Fossati G, Mascagni P, Dinarello CA (2010) The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4+ T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro. J Acquir Immune Defic Syndr 54(1):1\u20139","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5\u20136","key":"3662_CR18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2119\/molmed.2011.00076","volume":"17","author":"S Matalon","year":"2011","unstructured":"Matalon S, Rasmussen TA, Dinarello CA (2011) Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir. Mol Med 17(5\u20136):466\u2013472","journal-title":"Mol Med"},{"issue":"11","key":"3662_CR19","doi-asserted-by":"crossref","first-page":"e48832","DOI":"10.1371\/journal.pone.0048832","volume":"7","author":"H Ying","year":"2012","unstructured":"Ying H, Zhang Y, Zhou X, Qu X, Wang P, Liu S, Lu D, Zhu H (2012) Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB. PLoS ONE 7(11):e48832. doi: 10.1371\/journal.pone.0048832","journal-title":"PLoS ONE"},{"issue":"5","key":"3662_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/hv.23800","volume":"9","author":"TA Rasmussen","year":"2013","unstructured":"Rasmussen TA, Schmeltz S\u00f8gaard O, Brinkmann C, Wightman F, Lewin SR, Melchjorsen J, Dinarello C, \u00d8stergaard L, Tolstrup M (2013) Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation. Hum Vaccin Immunother 9(5):13\u201321. doi: 10.4161\/hv.23800","journal-title":"Hum Vaccin Immunother"},{"issue":"22","key":"3662_CR21","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.febslet.2011.10.018","volume":"585","author":"W Bernhard","year":"2011","unstructured":"Bernhard W, Barreto K, Saunders A, Dahabieh MS, Johnson P, Sadowski I (2011) The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response. FEBS Lett 585(22):3549\u20133554","journal-title":"FEBS Lett"},{"issue":"22","key":"3662_CR22","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1074\/jbc.M110.103531","volume":"285","author":"K Imai","year":"2010","unstructured":"Imai K, Togami H, Okamoto T (2010) Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 285(22):16538\u201316545","journal-title":"J Biol Chem"},{"issue":"17","key":"3662_CR23","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1128\/JVI.00836-11","volume":"85","author":"J Friedman","year":"2011","unstructured":"Friedman J, Cho W-K, Chu CK, Keedy KS, Archin NM, Margolis DM, Karn J (2011) Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. J Virol 85(17):9078\u20139089","journal-title":"J Virol"},{"issue":"12","key":"3662_CR24","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/BF01933991","volume":"33","author":"S Zayed","year":"1977","unstructured":"Zayed S, Hafez A, Adolf W, Hecker E (1977) New tigliane and daphnane derivatives fromPimelea prostrata andPimelea simplex. Experientia 33(12):1554\u20131555","journal-title":"Experientia"},{"issue":"40","key":"3662_CR25","doi-asserted-by":"crossref","first-page":"42008","DOI":"10.1074\/jbc.M402124200","volume":"279","author":"SA Williams","year":"2004","unstructured":"Williams SA, Chen L-F, Kwon H, Fenard D, Bisgrove D, Verdin E, Greene WC (2004) Prostratin antagonizes HIV latency by activating NF-\u03baB. J Biol Chem 279(40):42008\u201342017","journal-title":"J Biol Chem"},{"issue":"6","key":"3662_CR26","doi-asserted-by":"crossref","first-page":"e11160","DOI":"10.1371\/journal.pone.0011160","volume":"5","author":"R Mehla","year":"2010","unstructured":"Mehla R, Bivalkar-Mehla S, Zhang R, Handy I, Albrecht H, Giri S, Nagarkatti P, Nagarkatti M, Chauhan A (2010) Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner. PLoS ONE 5(6):e11160","journal-title":"PLoS ONE"},{"issue":"6","key":"3662_CR27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/157016210793499312","volume":"8","author":"M Perez","year":"2010","unstructured":"Perez M, de Vinuesa AG, Sanchez-Duffhues G, Marquez N, Bellido M, Munoz-Fernandez M, Moreno S, Castor TP, Calzado MA, Munoz E (2010) Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency. Curr HIV Res 8(6):418\u2013429","journal-title":"Curr HIV Res"},{"issue":"6","key":"3662_CR28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bcp.2008.11.025","volume":"77","author":"LM Bedoya","year":"2009","unstructured":"Bedoya LM, Marquez N, Martinez N, Gutierrez-Eisman S, Alvarez A, Calzado MA, Rojas JM, Appendino G, Munoz E, Alcami J (2009) SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro. Biochem Pharmacol 77(6):965\u2013978. doi: 10.1016\/j.bcp.2008.11.025","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"3662_CR29","doi-asserted-by":"crossref","first-page":"e26677","DOI":"10.1371\/journal.pone.0026677","volume":"6","author":"L Huang","year":"2011","unstructured":"Huang L, Ho P, Yu J, Zhu L, Lee K-H, Chen C-H (2011) Picomolar dichotomous activity of gnidimacrin against HIV-1. PLoS ONE 6(10):e26677","journal-title":"PLoS ONE"},{"issue":"16","key":"3662_CR30","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1128\/JVI.76.16.8118-8123.2002","volume":"76","author":"YD Korin","year":"2002","unstructured":"Korin YD, Brooks DG, Brown S, Korotzer A, Zack JA (2002) Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J Virol 76(16):8118\u20138123","journal-title":"J Virol"},{"issue":"2","key":"3662_CR31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1291\/hypres.31.315","volume":"31","author":"H Nakamoto","year":"2008","unstructured":"Nakamoto H, Ogasawara Y, Kajiya F (2008) Visualisation of the effects of dilazep on rat afferent and efferent arterioles in vivo. Hypertens Res 31(2):315\u2013324","journal-title":"Hypertens Res"},{"issue":"6","key":"3662_CR32","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1182\/blood.V90.6.2345","volume":"90","author":"H Deguchi","year":"1997","unstructured":"Deguchi H, Takeya H, Wada H, Gabazza E, Hayashi N, Urano H, Suzuki K (1997) Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes. Blood 90(6):2345\u20132356","journal-title":"Blood"},{"issue":"4","key":"3662_CR33","first-page":"339","volume":"36","author":"H Yoshida","year":"1994","unstructured":"Yoshida H, Kanatsu K, Muso E, Kuwahara T, Sekita K, Ono T, Konishi N, Kanda C, Minakata T, Morimoto K (1994) Effects of an anti-platelet drug (dilazep) in IgA nephropathy: comparison of clinical effects with renal biopsy findings. Nihon Jinzo Gakkai Shi 36(4):339\u2013344","journal-title":"Nihon Jinzo Gakkai Shi"},{"issue":"4","key":"3662_CR34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jps.2600780404","volume":"78","author":"M Sambhi","year":"1989","unstructured":"Sambhi M, Kannan R, Thananopavarn C, Ookhtens M, Gudenzi M (1989) Therapeutic tolerance, hemodynamic effects, and oral dose kinetics of dilazep dihydrochloride in hypertensive patients. J Pharm Sci 78(4):281\u2013284","journal-title":"J Pharm Sci"},{"issue":"2","key":"3662_CR35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2013.02.022","volume":"440","author":"D Ding","year":"2013","unstructured":"Ding D, Qu X, Li L, Zhou X, Liu S, Lin S, Wang P, Liu S, Kong C, Wang X, Liu L, Zhu H (2013) Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation. Virology 440(2):182\u2013189. doi: 10.1016\/j.virol.2013.02.022","journal-title":"Virology"},{"issue":"3","key":"3662_CR36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.antiviral.2013.10.010","volume":"100","author":"P Wang","year":"2013","unstructured":"Wang P, Qu X, Wang X, Liu L, Zhu X, Zeng H, Zhu H (2013) As2O3 synergistically reactivate latent HIV-1 by induction of NF-\u03baB. Antivir Res 100(3):688\u2013697","journal-title":"Antivir Res"},{"issue":"3","key":"3662_CR37","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1128\/JVI.77.3.1659-1665.2003","volume":"77","author":"D Persaud","year":"2003","unstructured":"Persaud D, Zhou Y, Siliciano JM, Siliciano RF (2003) Latency in human immunodeficiency virus Type 1 infection: no easy answers. J Virol 77(3):1659\u20131665. doi: 10.1128\/jvi.77.3.1659-1665.2003","journal-title":"J Virol"},{"issue":"9485","key":"3662_CR38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","volume":"366","author":"G Lehrman","year":"2005","unstructured":"Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW (2005) Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366(9485):549\u2013555","journal-title":"Lancet"},{"key":"3662_CR39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/511823","volume":"195","author":"JD Siliciano","year":"2007","unstructured":"Siliciano JD, Lai J, Callender M, Pitt E, Zhang H, Margolick JB, Gallant JE, Cofrancesco J, Moore RD (2007) Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. J Infect Dis 195:833\u2013836","journal-title":"J Infect Dis"},{"issue":"10","key":"3662_CR40","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/QAD.0b013e3282fd6ddc","volume":"22","author":"N Sagot-Lerolle","year":"2008","unstructured":"Sagot-Lerolle N, Lamine A, Chaix M-L, Boufassa F, Aboulker J-P, Costagliola D, Goujard C, Paller C, Delfraissy J-F, Lambotte O (2008) Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir. AIDS 22(10):1125\u20131129","journal-title":"AIDS"},{"issue":"19","key":"3662_CR41","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1128\/JVI.78.19.10507-10515.2004","volume":"78","author":"A Biancotto","year":"2004","unstructured":"Biancotto A, Grivel J-C, Gondois-Rey F, Bettendroffer L, Vigne R, Brown S, Margolis LB, Hirsch I (2004) Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. J Virol 78(19):10507\u201310515","journal-title":"J Virol"},{"issue":"11\u201312","key":"3662_CR42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2012.12.008","volume":"18","author":"S Xing","year":"2013","unstructured":"Xing S, Siliciano RF (2013) Targeting HIV latency: pharmacologic strategies toward eradication. Drug Discov Today 18(11\u201312):541\u2013551. doi: 10.1016\/j.drudis.2012.12.008","journal-title":"Drug Discov Today"},{"issue":"9","key":"3662_CR43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nchembio817","volume":"2","author":"JB Fitzgerald","year":"2006","unstructured":"Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK (2006) Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 2(9):458\u2013466","journal-title":"Nat Chem Biol"},{"issue":"10\u201312","key":"3662_CR44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","volume":"1799","author":"SC Gupta","year":"2010","unstructured":"Gupta SC, Sundaram C, Reuter S, Aggarwal BB (2010) Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 1799(10\u201312):775\u2013787. doi: 10.1016\/j.bbagrm.2010.05.004","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"3662_CR45","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1074\/jbc.M807898200","volume":"284","author":"X Contreras","year":"2009","unstructured":"Contreras X, Schweneker M, Chen CS, McCune JM, Deeks SG, Martin J, Peterlin BM (2009) Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem 284(11):6782\u20136789. doi: 10.1074\/jbc.M807898200","journal-title":"J Biol Chem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3662-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-014-3662-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3662-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T22:05:51Z","timestamp":1598133951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-014-3662-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["3662"],"URL":"https:\/\/doi.org\/10.1007\/s11033-014-3662-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]}}}